Company news

NeuroOne Medical Technologies Corporation news in 2023

NeuroOne Medical Technologies Corporation's news releases, calls and decks from 2023, newest first.

View company

NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update

December 13, 2023

NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System

December 10, 2023

NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14

December 6, 2023

NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe

November 15, 2023

NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

November 13, 2023

NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System

November 6, 2023

NeuroOne® to Present at the ThinkEquity Conference on October 19, 2023

October 12, 2023

NeuroOne® to Present at the H.C. Wainwright 25th Annual Global Investment Conference

September 5, 2023

NeuroOne® Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update

August 13, 2023

NeuroOne® to Report Third Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on August 14

August 7, 2023

NeuroOne Medical Technologies Corporation Announces Pricing of Public Offering of Common Stock

July 24, 2023

NeuroOne® Submits 510(k) Application to FDA for OneRF™ Ablation System

June 11, 2023

NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode in Robotic Neurosurgery

May 16, 2023

NeuroOne® to Report Second Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on May 11

May 10, 2023

NeuroOne® Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update

May 10, 2023

NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode Performed at Mayo Clinic

May 9, 2023

NeuroOne® to Present at the Sidoti Micro-Cap Virtual Conference on May 10

May 4, 2023

NeuroOne® Announces U.S. Commercial Launch of Evo® sEEG Electrodes

May 1, 2023

NeuroOne® Successfully Completes Initial Animal Implant of Novel Thin Film Paddle Lead for Spinal Cord Stimulation

March 15, 2023

NeuroOne®#¹⁶⁰;to Participate in the 35th Annual Roth Conference

March 8, 2023

NeuroOne® Awarded U.S. Patent Covering Novel and Proprietary Thin Film Electrode Platform

March 6, 2023

NeuroOne® Reports First Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update

February 13, 2023

NeuroOne® to Report First Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on February 14

February 8, 2023

Calls in 2023